---
title: "Denali Therapeutics (DNLI) Receives a Buy from UBS"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289921157.md"
description: "UBS analyst Michael Yee maintained a Buy rating on Denali Therapeutics (DNLI) with a $25 price target. While Yee holds a 2-star rating, the broader analyst consensus for DNLI is a Strong Buy with an average price target of $35."
datetime: "2026-06-16T12:36:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289921157.md)
  - [en](https://longbridge.com/en/news/289921157.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289921157.md)
generator: "portal-rs"
---

# Denali Therapeutics (DNLI) Receives a Buy from UBS

In a report released today, Michael Yee from UBS maintained a Buy rating on Denali Therapeutics, with a price target of $25.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
-   Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.

According to TipRanks, Yee is a 2-star analyst with an average return of 0.4% and a 43.55% success rate. Yee covers the Healthcare sector, focusing on stocks such as Pfizer, Oruka Therapeutics, and Biogen.

Currently, the analyst consensus on Denali Therapeutics is a Strong Buy with an average price target of $35.00.

### Related Stocks

- [DNLI.US](https://longbridge.com/en/quote/DNLI.US.md)
- [UBS.US](https://longbridge.com/en/quote/UBS.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [ORKA.US](https://longbridge.com/en/quote/ORKA.US.md)
- [BIIB.US](https://longbridge.com/en/quote/BIIB.US.md)

## Related News & Research

- [Denali Therapeutics COFO, Secretary Alexander Schuth disposes of 2,768 common shares for $64,881.92](https://longbridge.com/en/news/297954542.md)
- [B. Metzler seel. Sohn & Co. AG Buys New Stake in Denali Therapeutics Inc. $DNLI](https://longbridge.com/en/news/296694335.md)
- [AXQ Capital LP Takes Position in TG Therapeutics, Inc. $TGTX](https://longbridge.com/en/news/298125485.md)
- [Maze Therapeutics (NASDAQ:MAZE) Insider Sells 1,981 Shares of Stock](https://longbridge.com/en/news/298109715.md)
- [ADC Therapeutics CEO joins Cantor Global Healthcare Conference fireside chat](https://longbridge.com/en/news/297904155.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**